MGRC’s erratic share price
FOR a company still being an affected listed corporation pursuant to Rule 8.03A of the listing rules, it is strange that the share price of Malaysian Genomics Resource Centre Bhd
(MGRC) had spiked to a high of RM2.57 on Nov 30.
At that price, the health technology company would have had to have profits of over RM31mil to justify a price earnings multiple of only 10 times.
